Patent details

EP1781606 Title: AZETIDINE DERIVATIVES AS CCR-3 RECEPTOR ANTAGONISTS

Basic Information

Publication number:
EP1781606
PCT Application Number:
PCT/EP/2005/008654
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP057769655
PCT Publication Number:
WO/2006/015854
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
AZETIDINE DERIVATIVES AS CCR-3 RECEPTOR ANTAGONISTS
French Title of Invention:
DÉRIVÉS D'AZETIDINE UTILES COMME DES ANTAGONISTES DU RÉCEPTEUR CCR-3
German Title of Invention:
AZETIDIN-DERIVATE ALS CCR-3-REZEPTOR-ANTAGONISTEN
SPC Number:

Dates

Filing date:
09/08/2005
Grant date:
05/08/2009
EP Publication Date:
05/08/2009
PCT Publication Date:
16/02/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
09/05/2007
EP B1 Publication Date:
05/08/2009
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
09/08/2009
Expiration date:
09/08/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/08/2005
 
 

Name:
NOVARTIS AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Name:
NOVARTIS-PHARMA GMBH
Address:
Brunner Strasse 59, 1230 Vienna, Austria (AT)

Inventor

Name:
LEGRAND Darren Mark
Address:
United Kingdom (GB)

Priority

Priority Number:
0417801
Priority Date:
10/08/2004
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
C07D 205/04;
Filing date Document type Number of pages